chemoenzymatic synthesis homogeneous ultralow molecular weight heparins 
ultralow molecular weight ulmw heparins sulfated glycans clinically used treat thrombotic disorders ulmw heparins range daltons corresponding saccharide units commercial drug arixtra fondaparinux sodium structurally homogeneous ulmw heparin pentasaccharide synthesized lengthy chemical process report step chemoenzymatic syntheses two structurally homogeneous ulmw heparins mw % overall yield respectively starting simple disaccharide ulmw heparins display excellent vitro anticoagulant activity comparable pharmacokinetic properties arixtra demonstrated rabbit model chemoenzymatic approach scalable shows promise efficient route synthesize important class medicinal agent 
